JO3251B1 - عملية لاستخلاص هيدروكلوريد النالميفين - Google Patents
عملية لاستخلاص هيدروكلوريد النالميفينInfo
- Publication number
- JO3251B1 JO3251B1 JOP/2012/0364A JOP20120364A JO3251B1 JO 3251 B1 JO3251 B1 JO 3251B1 JO P20120364 A JOP20120364 A JO P20120364A JO 3251 B1 JO3251 B1 JO 3251B1
- Authority
- JO
- Jordan
- Prior art keywords
- hydrochloride
- extraction
- nalmivine
- nalmifene
- morphenan
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title abstract 2
- 238000000605 extraction Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000004593 Epoxy Substances 0.000 abstract 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000012535 impurity Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA201100948 | 2011-12-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JO3251B1 true JO3251B1 (ar) | 2018-09-16 |
Family
ID=48573602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JOP/2012/0364A JO3251B1 (ar) | 2011-12-06 | 2012-12-04 | عملية لاستخلاص هيدروكلوريد النالميفين |
Country Status (32)
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105646508B (zh) * | 2016-02-17 | 2018-02-27 | 南京卓康医药科技有限公司 | 一种盐酸纳美芬一水合物的制备方法 |
| US10927121B1 (en) | 2019-12-20 | 2021-02-23 | Southwest Research Institute | Technologies for removing residual solvent from nalmefene hydrochloride and producing crystalline nalmefene hydrochloride monohydrate, monosolvate, or crystalline nalmefene hydrochloride dihydrate |
| US20240109907A1 (en) | 2021-01-28 | 2024-04-04 | Rhodes Technologies | Process for crystallizing nalmefene hydrochloride |
| CN117986261B (zh) * | 2024-04-02 | 2024-06-18 | 成都瑞尔医药科技有限公司 | 一种盐酸纳美芬母液的回收套用方法 |
| CN119080788A (zh) * | 2024-08-19 | 2024-12-06 | 南京海鲸药业股份有限公司 | 一种盐酸纳美芬杂质的去除监控系统及去除方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2577947A (en) * | 1951-12-11 | Manufacture of dihydrocodeinone | ||
| US3896226A (en) * | 1971-11-26 | 1975-07-22 | Lewinstein Evalina | 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts thereof, and use of the same as a narcotic antagonist |
| US3814768A (en) * | 1971-11-26 | 1974-06-04 | Lewenstein E | 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts |
| US4535157A (en) | 1983-11-01 | 1985-08-13 | Key Pharmaceuticals, Inc. | Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone |
| US4751307A (en) | 1985-01-17 | 1988-06-14 | Mallinckrodt, Inc. | Wittig-reaction processes |
| US5869669A (en) * | 1996-07-26 | 1999-02-09 | Penick Corporation | Preparation of 14-hydroxynormorphinones from normorphinone dienol acylates |
| EP1233966B2 (en) * | 1999-11-09 | 2011-10-19 | Abbott Laboratories | Hydromorphinone and hydrocodeinone compositions and methods for their synthesis |
| CN1652752A (zh) * | 2002-03-14 | 2005-08-10 | 欧罗赛铁克股份有限公司 | 盐酸纳曲酮组合物 |
| AU2007224221B2 (en) * | 2006-03-02 | 2013-02-14 | SpecGx LLC | Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds |
| ES2393221T3 (es) * | 2006-12-04 | 2012-12-19 | Noramco, Inc. | Procedimiento de preparación de oxicodona con niveles reducidos de 14-hidroxicodeinona |
| WO2008094574A2 (en) | 2007-01-30 | 2008-08-07 | Biogen Idec Ma Inc. | Furanone compounds and methods of making and using the same |
| UA102128C2 (en) * | 2008-12-05 | 2013-06-10 | Х. Луннбек А/С | Nalmefene hydrochloride dihydrate |
| CN102459276B (zh) * | 2009-05-25 | 2016-09-21 | H.隆德贝克有限公司 | 从纳曲酮制备盐酸纳美芬 |
| CN101768164B (zh) * | 2010-01-25 | 2011-09-14 | 海南数尔药物研究有限公司 | 一种高纯度的盐酸纳洛酮化合物 |
-
2012
- 2012-11-22 TW TW101143647A patent/TWI560170B/zh not_active IP Right Cessation
- 2012-12-04 AR ARP120104552A patent/AR089080A1/es unknown
- 2012-12-04 JO JOP/2012/0364A patent/JO3251B1/ar active
- 2012-12-06 PT PT127979094T patent/PT2788357T/pt unknown
- 2012-12-06 JP JP2014545252A patent/JP6086925B2/ja active Active
- 2012-12-06 ME MEP-2017-75A patent/ME02668B/me unknown
- 2012-12-06 AU AU2012347261A patent/AU2012347261B2/en not_active Ceased
- 2012-12-06 CN CN201280067483.6A patent/CN104093721B/zh not_active Expired - Fee Related
- 2012-12-06 HR HRP20170497TT patent/HRP20170497T1/hr unknown
- 2012-12-06 LT LTEP12797909.4T patent/LT2788357T/lt unknown
- 2012-12-06 MX MX2014006705A patent/MX354331B/es active IP Right Grant
- 2012-12-06 SG SG11201402956UA patent/SG11201402956UA/en unknown
- 2012-12-06 SI SI201230923A patent/SI2788357T1/sl unknown
- 2012-12-06 US US14/294,707 patent/US8841452B1/en active Active
- 2012-12-06 CA CA2857096A patent/CA2857096C/en active Active
- 2012-12-06 SM SM20170200T patent/SMT201700200T1/it unknown
- 2012-12-06 WO PCT/EP2012/074623 patent/WO2013083685A1/en active Application Filing
- 2012-12-06 EP EP12797909.4A patent/EP2788357B1/en active Active
- 2012-12-06 KR KR1020147016975A patent/KR20140103288A/ko not_active Ceased
- 2012-12-06 RS RS20170349A patent/RS55817B1/sr unknown
- 2012-12-06 RU RU2014126489A patent/RU2631652C2/ru active
- 2012-12-06 DK DK12797909.4T patent/DK2788357T3/en active
- 2012-12-06 BR BR112014013541-0A patent/BR112014013541B1/pt not_active IP Right Cessation
- 2012-12-06 HU HUE12797909A patent/HUE033717T2/en unknown
- 2012-12-06 ES ES12797909.4T patent/ES2622156T3/es active Active
- 2012-12-06 PL PL12797909T patent/PL2788357T3/pl unknown
- 2012-12-06 IN IN1211KON2014 patent/IN2014KN01211A/en unknown
-
2014
- 2014-05-27 IL IL232826A patent/IL232826A/en active IP Right Grant
- 2014-06-03 CL CL2014001454A patent/CL2014001454A1/es unknown
- 2014-06-05 ZA ZA2014/04100A patent/ZA201404100B/en unknown
- 2014-06-06 CO CO14122226A patent/CO6970605A2/es active IP Right Grant
-
2017
- 2017-03-31 CY CY20171100389T patent/CY1118785T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL240215A0 (en) | Methods for the purification of messenger RNA | |
| IN2014DN08481A (forum.php) | ||
| ZA201306920B (en) | POTENT AND SELECTIVE INHIBITORS OF NAv1.3 AND NAv1.7 | |
| SMT202100325T1 (it) | Metodi e composizioni per l’inibizione specifica della glicolato ossidasi (hao1) mediante rna a doppio filamento | |
| IN2013MU03641A (forum.php) | ||
| JO3251B1 (ar) | عملية لاستخلاص هيدروكلوريد النالميفين | |
| IN2013MU01113A (forum.php) | ||
| NZ720805A (en) | Processes for the preparation of pyrimidinylcyclopentane compounds | |
| IN2014DN09451A (forum.php) | ||
| IN2014DN10209A (forum.php) | ||
| EP2654791A4 (en) | PROCESS FOR TREATING SYSTEMIC LUPUS ERYTHEMATODE WITH HIV PROTEASE INHIBITORS | |
| IN2013MU04056A (forum.php) | ||
| PT2981518T (pt) | Um processo melhorado para a preparação de maleato de fluvoxamina | |
| EP3009843A4 (en) | Method for determining dosage of erythropoiesis-stimulating agent | |
| WO2014128728A3 (en) | Solid forms of cabazitaxel and processes for preparation thereof | |
| WO2014008204A3 (en) | Structures of proteasome inhibitors and methods for synthesizing and use thereof | |
| MX391523B (es) | Intermediarios y metodos para sintetizar derivados de calicheamicina | |
| WO2014174529A3 (en) | Polymorphs of avanafil | |
| IN2013MU01219A (forum.php) | ||
| IN2013MU03768A (forum.php) | ||
| HK40117898A (en) | Methods for purification of messenger rna | |
| MX361888B (es) | Un procedimiento mejorado para producir zilpaterol. | |
| SG10201801824SA (en) | Agent for reducing catabolism or promoting assimilation of protein | |
| IN2013MU03469A (forum.php) | ||
| IN2013CH05591A (forum.php) |